chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received a FLUZONE HD PF 17-18 PFS immunization. Pain, swelling, hardness, ache at place of injection and small hole about 2 hours after injection. Felt extreme pain in joints and muscles enough to interrupt sleep. Felt similar flu-like symptoms (aches and pains) and felt ill for 48 hours after injection. This was the most extreme joint/muscle pain I've ever felt. I've had similar reactions, but not so extreme to other flu vaccinations.
Neck is breaking out; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Neck is breaking out) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (Neck is breaking out). At the time of the report, RASH (Neck is breaking out) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported.  No treatment medication were reported.
Congestion by that next morning, severe cough, then sudden high spiked fever. Has been going on for a week now. Said it was a virus, but has now started to irritate the lungs. Baby is lethargic and barely eating.
pt experienced syncope, fever, shaking and fainted hours after the shot.  pt treated symptoms with Tylenol and Motrin.  symptoms lasted about 12 hours.
1115 PT C/O NAUSEA. CRACKER AND WATRER PROVIDED. PT WILL WAIT 5 MORE MIN. NO ACUTE SYMPTOMS NOTED. WILL CONTINUE TO MONITOR; 1120 PT STATED NAUSEA WAS EASED UP. PT WAS READY TO GO HOME. ADVISED PT TO SEE PRIMARY DOCTOR IF NAUSEA CONTINUES. PT VERBALIZED UNDERSTOOD
Mom reports pt broke out w/rash on inside of both arms & on back on 29OCT91 about 8PM; following immun given on 28OCT91 about 11AM; Describes rash as "small bumps close together that itch;
Administer expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) in a 30-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine). On 29-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided. No treatment given. The vaccine was stored in freezer, one to two vials were taken out and placed in the fridge each day as needed.
Immediately after injection I had  itching down my right arm and three bright red stripes underneath injection site appeared. In the following 10 to 15 minutes my lips started tingling and my throat started to tighten up. The itching finally stopped after 10 minutes. The tingling in my lips and throat tightening occurred with both the first and second dose. The staff kept me for around 45-50 minutes for both doses of the vaccine.  When going home I took 2 Benadryl.
Heavy sweating; Emotional sensitivity; Loss of Appetite; Lost weight like 2 sizes down; Horrible feeling; Sore at injection site; Chills; Tiredness; This spontaneous case was reported by a patient and describes the occurrence of HYPERHIDROSIS (Heavy sweating), DEPRESSED MOOD (Emotional sensitivity), DECREASED APPETITE (Loss of Appetite), WEIGHT DECREASED (Lost weight like 2 sizes down) and FEELING ABNORMAL (Horrible feeling) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (Heavy sweating), DEPRESSED MOOD (Emotional sensitivity), DECREASED APPETITE (Loss of Appetite), WEIGHT DECREASED (Lost weight like 2 sizes down), FEELING ABNORMAL (Horrible feeling), VACCINATION SITE PAIN (Sore at injection site), CHILLS (Chills) and FATIGUE (Tiredness). At the time of the report, HYPERHIDROSIS (Heavy sweating), DEPRESSED MOOD (Emotional sensitivity), DECREASED APPETITE (Loss of Appetite), WEIGHT DECREASED (Lost weight like 2 sizes down), FEELING ABNORMAL (Horrible feeling), VACCINATION SITE PAIN (Sore at injection site), CHILLS (Chills) and FATIGUE (Tiredness) outcome was unknown.
Night of injection, (L) pain in arm. Next day, racing heart rate, weakness, headache, painful arm. Day 3 - red arm & swollen, continued headache, painful to move arm. Went to physician on Day 3. Dx - cellulitis. Received Cephalexin & doxycycline & Ibuprofen. Rec'd steroid shot x2. All symptoms in (L) arm. No (R) arm symptoms.
0.1 mL IPV mistakenly administered instead of the ordered PPD. No adverse outcomes observed
sick in her stomach all day long; Stayed in bed all day; pain in arm; chills; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (sick in her stomach all day long), SOMNOLENCE (Stayed in bed all day), PAIN IN EXTREMITY (pain in arm) and CHILLS (chills) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037132AA and 044821A) for COVID-19 vaccination.     Concurrent medical conditions included Eczema and Back disorder. Concomitant products included TRIAMCINOLONE and MELOXICAM for an unknown indication.   On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Apr-2021, the patient experienced ABDOMINAL DISCOMFORT (sick in her stomach all day long), SOMNOLENCE (Stayed in bed all day), PAIN IN EXTREMITY (pain in arm) and CHILLS (chills). At the time of the report, ABDOMINAL DISCOMFORT (sick in her stomach all day long), SOMNOLENCE (Stayed in bed all day), PAIN IN EXTREMITY (pain in arm) and CHILLS (chills) outcome was unknown.            No treatment information was provided.   This case was linked to MOD-2021-053095 (Patient Link).
Started with itching of stomach, progressed to swelling of left eye (swollen shut) and hives all over body with itching. Entire event occurred within 30 minutes. 911 was called, patient was given a dose of Benadryl and Albuterol nebulizer treatment.
Information has been received from a medical assistant(also reported as office manager) referring to a 12 month old patient of unknown gender. The patient's concurrent condition, medical history and concomitant therapy were not provided. On 26-APR-2017, the patient was vaccinated with the second improperly stored dose of VAQTA (lot # M039202, expiration date: 11-MAR-2018; dose and route of administration were not provided) for prophylaxis (Incorrect product storage). No adverse effects were reported. The vaccine was involved in Vaccines For Children Program (VFC) stock and the VFC status appointment was reported as 1. The patient received the vaccine with the temperature excursion of 17.6 degrees Celsius for 74 hours and 8 minutes (also reported as 1 hour and 38 minutes). The vaccine was previously exposed to a temperature excursion in 13 degrees Celsius for 72 hours 30 minutes. Data logger was involved. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information is not expected as all correspondence was received. ; Sender's Comments: US-009507513-1704USA014784:
Patient called today 5/17/2021 - reports of severe abdominal pain , menstrual bleeding with reported "tennis ball size blood clots" approximately 24 hours after receiving 1st COVID vaccine on 5/12/2021.  Patient reports she not sought medical attention - reports clots have gotten smaller - patient advised to see GYN - declined would rather see her PCP - patients reports scheduled appointment on 5/19/2021 with PCP .  Patient reports she is in menopause and currently not menstruating other than occasional spotting and feels this is related to her receiving the COVID vaccine and wanted to report these symptoms as instructed.
Initial report received from a health care professional on 21 November 2013. A male patient whose age, medical history and concomitant medications were not reported, received a dose of influenza vaccine (lot number: unknown, administration site and route was not reported) on 23 October 2013. Within 2 hours, patient complained of severe pain in the arm and shoulder of the injection site. Patient's primary care doctor who did an MRI and x-rays to r/o spine, nerve problems. He has since been seeing an orthopedic doctor and now doing physical therapy 3x week for a frozen shoulder. He has been receiving the flu shot yearly for 10 years with no problems. List of documents held by sender: none
fever of 101°F-103°F; not been able to keep anything beside clear liquids down. She cannot eat; did not feel good; not been able to keep anything beside clear liquids down. She cannot eat; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (did not feel good), DECREASED APPETITE (not been able to keep anything beside clear liquids down. She cannot eat), VOMITING (vomiting), PYREXIA (fever of 101°F-103°F) and NAUSEA (not been able to keep anything beside clear liquids down. She cannot eat) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018B21A and 048B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced FEELING ABNORMAL (did not feel good), DECREASED APPETITE (not been able to keep anything beside clear liquids down. She cannot eat), VOMITING (vomiting) and NAUSEA (not been able to keep anything beside clear liquids down. She cannot eat). On 23-Apr-2021, the patient experienced PYREXIA (fever of 101°F-103°F). At the time of the report, FEELING ABNORMAL (did not feel good), DECREASED APPETITE (not been able to keep anything beside clear liquids down. She cannot eat), VOMITING (vomiting), PYREXIA (fever of 101°F-103°F) and NAUSEA (not been able to keep anything beside clear liquids down. She cannot eat) outcome was unknown.            Treatment was reported as Tylenol. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine)  was Not applicable. No treatment medication provided by the reporter.
This literature marketed report as received from author refers to a 13 year old patient of unknown gender with sickle cell anemia. A single sickle cell center started a pilot screening program of antibody response to pneumococcal vaccination in patients with sickle cell disease (SCD). Patients were chosen for screening based on frequency of hospitalization and acute chest syndrome. Medical records of 5 patients less than 19 years old were reviewed to date for infections, pneumococcal vaccination, and response to pneumococcal vaccines. As a result 5 patients reviewed had different genotypes of SCD (2HbSS, 2 HbSC, and 1 Hemoglobin S-beta-thalassemia). Within this cohort, 1/5 (20 percent) had an adequate response to pneumococcal vaccination, defined as greater than 70 percent of serotype-specific pneumococcal IgG antibodies to 23 serotypes with serum levels of at least 1.3microgram/milliliter. On an unknown date, the patient was vaccinated with a dose of pneumococcal vaccine, polyvalent (23-valent)(manufacturer unknown)(lot number, expiry date, route and dose were not reported). On an unknown date, the 13 year old patient developed streptococcus pneumonia meningitis despite vaccination (medically significant). The outcome of the event was unknown. The author considered the events as related to Pneumococcal Vaccine, Polyvalent (23-valent)(manufacturer unknown). All 5 patients had received adequate vaccination with both polysaccharide and conjugate pneumococcal vaccines. The author concluded that the prevalence of sickle cell patients with low pneumococcal titers was unknown. Patients with SCD who had inadequate response to vaccination were at increased risk for invasive pneumococcal disease and could benefit from early, routine screening. If confirmed, poor response to pneumococcal vaccination may provide a rationale for continuing sickle cell patients on lifetime penicillin prophylaxis. Additional information has been requested.
my reaction to my second dose; I ran 105.4 temp for about 30 allergies; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION COMPLICATION (my reaction to my second dose) and PYREXIA (I ran 105.4 temp for about 30 allergies) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Environmental allergy, Food allergy and Drug allergy.    On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (my reaction to my second dose) and PYREXIA (I ran 105.4 temp for about 30 allergies). At the time of the report, VACCINATION COMPLICATION (my reaction to my second dose) and PYREXIA (I ran 105.4 temp for about 30 allergies) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 105.4 (High) High.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter.                            Treatment information was not provided by the reporter.
This spontaneous report as received from a health professional refers to an unspecified number of patients of unknown age. On 20-SEP-2013 the unspecified number of patients might be vaccinated with GARDASIL (Lot#, dose and route not required). The health care worker reported the GARDASIL were out of temperature range and were not supported by their in house stability data and an unspecified number of patients (not patient information known at that time) might have been administered the vaccines. No adverse effects were reported. No PQC (Product Quality Complaints) was involved. It was unspecified if the patients had sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
Little sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Little sore arm) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 026A21A) for COVID-19 vaccination.     The patient's past medical history included Hypertension. Concurrent medical conditions included Diabetes.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE PAIN (Little sore arm). At the time of the report, VACCINATION SITE PAIN (Little sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to US-MODERNATX, INC.-MOD-2021-049855 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-049855:Crosslinked with dose 2
This spontaneous report as received from a female patient of unknown age refers to herself. The patient had tested positive for HPV in 2008. In 2009 the patient was vaccinated with series of GARDASIL (dose, route and lot number unspecified). The patient stated that throughout 2010 she had clean pap smears and no presence of HPV. Last week, in February 2014, she had a pap smear and tested positive for HPV. The outcome of the patient was unknown. The relationship was not assessed. Additional information is not expected.
She got the vaccine, on Friday she was running a light fever, coughing, tightness in her chest.  Friday she called the clinic and they told her to take cough drops, and OTC medications for the symptoms.  On 1/22/22 she called them again and she was advised to go to the office on 1/24/22 for COVID test, did so and was a 48 test, got the results on 1/26/22 that they were negative.  By then she was not doing good, you had coughing green sputum, running out of her nose like water (green), light fever of 99, trouble breathing with shortness of breath, and went to the ER.  They did a breathing treatment, they gave her a Ventolin inhaler, a steroid shot, they advised her to see her PCP in 7 days.   While in the ER she had a 2nd COVID test that was negative also.  They told her that they did not have the reason for her symptoms, but if they continue to return to the ER or go to the PCP.  Diagnosed with acute bronchial spasm.    She had to go out of town to bury her nephew who was killed.  On 2/2/22 she went to CHC and was given a Z-Pak, and a cough syrup Promethezine DM.  She was afraid that she had gotten COVID as she felt bad.  She saw doctor at the clinic.  This did help her, but she still has wheezing when she takes a deep breath, and still coughing up sputum.
Infant has acquired a permanent (scar) bruise from vaccination administered by health dept on 3/10/2000, on her right thigh during her 4 month immunization. Our concerns are justified because of the time elapsed for 2 months and bruise did not eventually go away. Also, the person performing the immunization was evidently training or inexperienced because she was receiving verbal instructions from another nurse.Annual follow-up dated 09/27/00 provided no additional data.
Onset from administration of Pfizer-BioNTech COVID 19 Vaccine EUA.  Body aches, eye soreness, fatigue, headache, dry cough off and on.  Onset was the first night that I received the vaccine, continued on and off the first week for a few days and then occurred and stayed continually most of the second week.
0.3ml dose was withdrawn from the un-reconstituted vial (120 mcg - 4x recommended dose of 30 mcg) and administered onto the right deltoid. No sign/symptoms of immediate reactions such as shortness of breath, urticaria, angioedema, nausea/vomiting, or diarrhea were reported. Vital signs were stable. Patient was admitted into the ED for 24 hour observation.
Within two minutes near syncope; severe nausea. Within two weeks the patient began exhibiting seizure like activity. Head/neck jerking, arm/leg/hand jerking daily during waking and sleeping hours. This is ongoing to date. Has no history of epilepsy or tremors prior to this.
Stared off to side. Loss of consciousness, turned blue, not responsive for 3 minutes.
INSOMNIA,  FEVER  AND CHILLS  ARM SORE, RED AND SWOLLEN LEFT EYELID DROOP ALL TREATED AT HOME, NO MEDICAL DR VISIT, PATIENT WANTED ME TO REPORT
The patient mother states after receiving the covid vaccine within 30 mins the patient had mild right eye swelling and excess blinking. Gave patient benadryl.
pt recv vax 1OCT97 & same day pt exp myalgia w/a fever of greater than 100;pt fever resolved p/1wk;
After receiving the first dose of vaccine on 05Mar2021, the patient went for antibody test ) and received a negative test result; This spontaneous case was reported by a pharmacist and describes the occurrence of SARS-COV-2 ANTIBODY TEST NEGATIVE (After receiving the first dose of vaccine on 05Mar2021, the patient went for antibody test ) and received a negative test result) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     The patient's past medical history included Osteoporosis in 2006. Concurrent medical conditions included Allergy to antibiotic (minocin). Concomitant products included DENOSUMAB (PROLIA) for Osteoporosis, CALCIUM and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-May-2021, the patient experienced SARS-COV-2 ANTIBODY TEST NEGATIVE (After receiving the first dose of vaccine on 05Mar2021, the patient went for antibody test ) and received a negative test result). On 14-May-2021, SARS-COV-2 ANTIBODY TEST NEGATIVE (After receiving the first dose of vaccine on 05Mar2021, the patient went for antibody test ) and received a negative test result) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In December 2020, SARS-CoV-2 antibody test: negative (Negative) negative. On 05-Mar-2021, SARS-CoV-2 antibody test: negative (Negative) negative.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No information regarding corrective treatment was reported by the patient.   This case was linked to MOD-2021-141821 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 26-Jun-2021: Follow up received which included patient details, patient medical history and concomitant medications.
In the first 24-48 hours I experienced -more or less, typical- effects such as: fatigue, headache, trouble focusing/sluggish, chills (likely fever) and pain in the are of the injection site. However, about 48 hours after  receiving the vaccine, the pain in the arm grew to a red splotchy rash, extremely hot to the touch and itchy in the entire shoulder area, reaching midway down the arm (but above the elbow)... this has been going on for 5-6 days.  I have iced, taken Tylenol and now Benadryl.
6 hours post shot: arm swelling  24 hours post shot: very tired, weak, unable to eat solids. Arm pain. Swollen arm. 48 hours: arm pain  8 days post shot: small rash The rash grew 3x the size within 24 hours. In a lot of pain. Felt weak and tired. Have had a headache since 3/27/21  3/29/21 semi lost taste. everything tastes bland. still have headache. overall not feeling the best.
15 to 30min p/vax pt devel h/a, nausea, ?sweaty & tight feeling in lt lateral neck;pt did return on 21AUG98 w/similar vague sx & was dx w/pyelonephritis;
Fever, chills, nausea, mild headache, and a strange taste in my mouth began at 8:30-9 pm the same evening of the second dose of Moderna Covid 19. All symptoms except the strange taste persisted for 24 hours from onset. The strange taste lasted an additional 24 hours (48 hours total) making any food taste weird.
Left thigh swollen- was red x 2 days. Pain which subsided after a few hrs.
Patient came in to clinic today stating she got the second dose of COVID vaccine on Friday, March 19, 2021 and noticed she got a rash on her shoulders and lower back on Saturday morning. Patient stated she noticed a rash was one of the side effects listed on the paper she got at time of vaccine. Patient has never gotten a reaction to vaccines in the past or to the first dose of COVID vaccine. Provider ordered 10mg of Dexamethazone and I administered it in pt right deltoid. Pt wait x15mins and left clinic with no adverse reactions that were observed within the clinic.